A Study of Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)

NCT00349596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphocytic Leukemia

Interventions

DRUG: Decitabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]